ADAP

Adaptimmune Therapeutics

62 hedge funds and large institutions have $27.7M invested in Adaptimmune Therapeutics in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 19 reducing their positions, and 11 closing their positions.

Holders
62
Holders Change
-5
Holders Change %
-7.46%
% of All Funds
0.83%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
10
Increased
8
Reduced
19
Closed
11
Calls
$8K
Puts
Net Calls
+$8K
Net Calls Change
-$11K
Name Market Value Shares Shares
Change
Shares
Change %
RBI
51
Raiffeisen Bank International
Austria
$218 907
GC
52
Garde Capital
Washington
$180 750 +750 New
WSFS
53
Wilmington Savings Fund Society
Delaware
$145 604
HWM
54
HighMark Wealth Management
Minnesota
$69 287
PA
55
Parallel Advisors
California
$60 250
BNP Paribas Financial Markets
56
BNP Paribas Financial Markets
France
$51 213
T
57
Transce3nd
Texas
$42 175
Northwestern Mutual Wealth Management
58
Northwestern Mutual Wealth Management
Wisconsin
$37 153 +153 New
IRC
59
Investors Research Corp
Georgia
$24 100
KHC
60
Koesten Hirschmann & Crabtree
Kansas
$12 47 +47 New
TWC
61
TD Waterhouse Canada
Ontario, Canada
$3 14
SS
62
SBI Securities
Japan
$2 10
Two Sigma Investments
63
Two Sigma Investments
New York
-135,947 Closed
Millennium Management
64
Millennium Management
New York
-94,283 Closed
GCM
65
Graham Capital Management
Connecticut
-87,274 Closed
Invesco
66
Invesco
Georgia
-78,031 Closed
CL
67
CSS LLC
Illinois
-30,702 Closed
HSBC Holdings
68
HSBC Holdings
United Kingdom
-26,064 Closed
Goldman Sachs
69
Goldman Sachs
New York
-16,149 Closed
Qube Research & Technologies (QRT)
70
Qube Research & Technologies (QRT)
United Kingdom
-10,113 Closed
BT
71
Banque Transatlantique
France
-1,824 Closed
Group One Trading
72
Group One Trading
Illinois
-147 Closed
FFA
73
Farther Finance Advisors
California
-20 Closed
Simplex Trading
74
Simplex Trading
Illinois
Citadel Advisors
75
Citadel Advisors
Florida